COMMUNIQUÉS West-GlobeNewswire

Endocyte to Join the Russell 3000® Index
25/06/2018
WEST LAFAYETTE, Ind., June 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that its common stock [...]
Savara Joins Russell 3000® Index
25/06/2018
AUSTIN, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ:SVRA), an orphan lung disease company, announced today that the company has been added to the broad-market Russell 3000 Index. “In the little more [...]
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25/06/2018
Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant [...]
Atara Biotherapeutics Opens State-of-the-Art Operations and Manufacturing Facility to Support Robust Off-the-Shelf T-Cell Immunotherapy Pipeline
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
ContraVir Pharmaceuticals Initiates Dosing of CRV431 in First In-Human Trial
25/06/2018
Corporate, Business and Clinical Update Conference Call and Live Audio Webcast Scheduled for Today at 4:30 p.m. ET EDISON, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a [...]
Additional Positive Afrezza® Clinical Data from STAT Study To Be Presented at ADA 78th Scientific Sessions
25/06/2018
Oral presentation (348-OR) at 5:00 pm today Afrezza provides greater improvement in post-prandial glucose control than insulin aspart WESTLAKE VILLAGE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation ( [...]
Cocrystal Pharma Announces Inclusion in Russell Microcap® Index
25/06/2018
ATLANTA, GA and BOTHELL, WA, June 25, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]
CymaBay Therapeutics Added to the Russell 3000® and Russell 2000® Indexes
25/06/2018
NEWARK, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet [...]
AMITA Health Selects R1 RCM for End-to-End Revenue Cycle Management
25/06/2018
Presence Health Agreement Signed CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today [...]
CLS Holdings USA Announces Closing of Oversubscribed C$13.0 Million Private Placement
25/06/2018
TORONTO and LAS VEGAS, June 25, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a development stage diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce the [...]
PDC Hosts 8th Annual Brady Walk for Community to Raise Funds for Local Charities in Southern California
25/06/2018
Proceeds will be Donated to Michael Hoefflin Foundation and Speak Out Against Bullying VALENCIA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- PDC , a global leader of innovative identification solutions, will host the 8 th [...]
PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
25/06/2018
PositiveID ExcitePCR subsidiary develops FireflyDX products for rapid, portable biothreat detection, a key to containment DELRAY BEACH, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “ [...]
Tyme Technologies, Inc. Set to Join Russell 3000® Index
25/06/2018
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced it is set to join the Russell 3000 [...]
Vital Therapies Joins the Russell 3000 Index®
25/06/2018
SAN DIEGO, June 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, announced it [...]
Evelo Biosciences Added To Russell 3000®, 2000® and Microcap® Indexes
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company pioneering monoclonal microbials designed to act on the gut-body network for the [...]
Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions
25/06/2018
Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD [...]
Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the Inaugural AACR International Meeting Advances in Malignant Lymphoma
25/06/2018
- G100 directly targets and modifies TLR4 expressing malignant B cells making them more visible to the anti-tumor immune response- SEATTLE and SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Immune Design [...]
Celsion Corporation to Join Russell Microcap® Index
25/06/2018
LAWRENCEVILLE, N.J., June 25, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that it will be added to the Russell Microcap® Index as part of the [...]
Cannabis Leaf (PCFP) Completes Merger with Apotheca Biosciences – Company’s R & D Focuses on Opioid Crisis, a National Public Health Emergency
25/06/2018
Saint Petersburg, FL, June 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, formulation and cannabis delivery technologies for the healthcare and [...]

Pages